NCT05491980 · ACTIVE NOT RECRUITING
Florida Cerebrovascular Disease Biorepository and Genomics Center
This is not a drug or treatment trial. It is a Florida research project building a biorepository: a bank of blood samples and medical histories from people with cerebrovascular disease, such as stroke, TIA, brain bleeds, and vascular dementia. Researchers may use them in future studies. No phase is listed. Nothing is being tested yet.
Eligibility criteria
Inclusion Criteria: • Affected subjects with diverse cerebrovascular conditions, including, but not limited to, ischemic stroke, transient ischemic attack (TIA), intracerebral hemorrhage (ICH), aneurysmal subarachnoid hemorrhage (aSAH), vascular dementia (VAD), anoxic brain injury, unruptured intracranial aneurysm (UIA), cavernous malformation, arteriovenous malformations (AVM), carotid and vertebral arterial dissections, symptomatic and asymptomatic cervical carotid artery atherosclerotic stenosis, non-aneurysmal perimesencephalic subarachnoid hemorrhage (naSAH), cerebral venous thrombosis (CVT), moyamoya disease, fibrosmuscular dysplasia (FMD), non-traumatic, angiography-negative subarachnoid hemorrhage, leukoaraiosis, arteriovenous fistula, reversible cerebral vasoconstriction syndrome (RCVS), and CADASIL. Exclusion Criteria: • All patients with the following known or suspected virulent microorganisms causing an active or latent infection will be excluded from the study: * Human immunodeficiency virus (HIV); * Any viral hepatitis; * West Nile virus (WNV); * Influenza virus; * Tuberculosis (TB); * Any bacteremia; * Any fungemia; * Any prionopathy.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-09-03